Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? Yes
Write-up: respiratory congestion with desaturation (no quantified value).; respiratory congestion with desaturation (no quantified value).; inhalation lung disease; Distress respiratory; Pneumonia aspiration; This is a spontaneous report from physician downloaded from the Regulatory Authority-WEB FR-AFSSAPS-MA20210469. A 95-years-old female patient received first dose of bnt162b2 (COMIRNATY, lot EJ6788), intramuscular in left arm on 09Feb2021 at single dose for covid-19 immunisation. Medical history included ATCD COVID-19 yes in October 2020, without respiratory failure, severe Alzheimer''s disease with total gabatization, bedridden. The patient''s concomitant medications were not reported. The patient experienced distress respiratory on 10Feb2021, pneumonia aspiration on 10Feb2021, appearance of respiratory congestion with desaturation (no quantified value) on 10Feb2021 09:00 p.m. Diagnosis of inhalation lung disease. The patient underwent lab tests and procedures which included Covid test: negative on 11Feb2021 at 7 a.m. The patient died on 12Feb2021. It was not reported if an autopsy was performed. The seriousness criteria was death, hospitalization, life threatening. No follow-up attempts are possible, information on batch number already obtained.; Reported Cause(s) of Death: Distress respiratory; Pneumonia aspiration; respiratory congestion; desaturation; inhalation lung disease
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166